WHERE INDIA STANDS IN FIGHTING TB, DESPITE MISSING 2025 TARGET

18 Nov 2026

Tags: Social Justice   Social Services   Health sector issues

Source: The Indian Express

Context: India has made progress in reducing tuberculosis (TB) mortality and expanding diagnostic facilities but has missed its 2025 target of eliminating TB. The latest WHO Global TB Report also highlights gaps in India's incidence data due to the transition towards district-level surveillance.

India's Progress in TB Control

Reduction in TB Mortality

  • Progress (2015–2025): TB mortality declined by 38%, from 28 deaths per lakh population in 2015 to 18 deaths per lakh in 2025.
  • Target Gap: India has missed the 2025 target of reducing TB mortality by 75%.

Improvement in Diagnostics

  • Rapid Diagnostic Testing: Accounted for 46% of all TB cases in 2025, enabling quicker diagnosis and timely treatment.
  • Active Case Finding: India conducted a large-scale screening exercise over the preceding two years under the TB Mukt Bharat Abhiyan.
  • Screening (2024): Approximately 25 crore people were screened, including 11 crore through chest X-rays, which can identify TB even in asymptomatic individuals.
  • New Diagnostic Methods: The national programme has incorporated newer testing methodologies to improve early detection.

Increased Domestic Funding: While global funding for TB declined by approximately 14%, India witnessed an increase in domestic funding for TB control.

Gaps in TB Incidence Data and Surveillance

  • Missing Incidence Estimates: India's estimated TB incidence was not included in the latest WHO Global TB Report because new district-level surveillance data is being analysed.
  • Pending Revision: Estimates of TB incidence and associated indicators are under review and are expected to be updated in early 2027.
  • Importance of Incidence Data: The difference between estimated TB cases and officially reported cases helps indicate the burden of undiagnosed and unreported infections.
  • Previous National Surveys: India conducted two national TB prevalence surveys, during 1955–58 and 2020–21, which provided the basis for estimating disease prevalence and incidence.
  • District-Level Surveillance (2025): India introduced District-Level Sentinel Surveillance (DLSS) to assess population-level trends in TB disease and infection.
  • Methodology: Uses cluster sampling and covers 300 clusters across 50 districts, involving an eligible population of approximately 1.5 lakh people.
  • Frequency: Future surveillance rounds are planned every 2–3 years.
  • Need for Data Validation: WHO emphasises examining trends and comparability with the 2020–21 national TB prevalence survey before finalising revised estimates.
  • Limitation: National prevalence surveys provide more comprehensive estimates but are resource-intensive and cannot be conducted frequently.

Global End TB Targets: The WHO established global targets to reduce TB incidence, mortality and catastrophic costs, using 2015 as the baseline year.

Target yearReduction in TB deaths
202035%
202575%
203090%
203595%
  • Global Challenge: TB continues to be the world's largest infectious-disease killer.
  • Target Achievement: India, like most countries, is unlikely to achieve the stipulated targets, highlighting the need for sustained efforts and adequate funding.

Challenges in Eliminating TB in India

  • Undiagnosed Cases: Inadequate detection and the gap between estimated and reported cases allow continued transmission.
  • Diagnostic Limitations: Although rapid testing has expanded, universal access to timely and accurate diagnosis remains a challenge.
  • Surveillance Gaps: Delays in updating incidence estimates make it difficult to accurately assess disease burden and programme effectiveness.
  • Funding Requirements: Sustained domestic financing is essential amid declining global TB funding.
  • Treatment Challenges: Delayed diagnosis, treatment interruption and drug-resistant TB complicate disease elimination.

Way Forward

  • Strengthen Active Case Finding: Expand community-level screening, particularly among vulnerable and high-risk populations.
  • Improve Diagnostics: Increase access to rapid molecular tests and chest X-ray-based screening.
  • Reliable Surveillance: Regularly update incidence estimates using robust national and district-level data.
  • Sustained Financing: Strengthen domestic funding and international partnerships for TB prevention, diagnosis and treatment.
  • Drug-Resistant TB Management: Ensure early detection and effective treatment of multidrug-resistant TB (MDR-TB).
  • Community Participation: Address stigma, improve awareness and ensure treatment adherence through community-based interventions.

Important Concepts for UPSC

Tuberculosis (TB)

  • Causative Agent: Mycobacterium tuberculosis, a bacterium.
  • Transmission: Primarily spreads through the air when infected individuals release infectious particles by coughing, sneezing or speaking.
  • Commonly Affected Organ: Lungs (pulmonary TB), although it can affect other organs (extrapulmonary TB).
  • Symptoms: Persistent cough, fever, night sweats, weight loss and fatigue.
  • Prevention: Early diagnosis, complete treatment, infection control and BCG vaccination.

TB Incidence vs. Prevalence

ParameterIncidencePrevalence
MeaningNew cases occurring during a specified periodTotal existing cases at a particular time or during a specified period
IndicatesRisk of developing TBOverall disease burden
UseTracks new transmission and disease occurrenceHelps assess healthcare requirements and disease burden

District-Level Sentinel Surveillance (DLSS)

  • Population-based surveillance system to monitor trends in TB disease and infection.
  • Uses cluster sampling to collect representative data from selected districts.
  • Helps improve disease-burden estimates and identify geographical variations.

Global End TB Strategy

  • Adopted by the WHO World Health Assembly in 2014.
  • Aims to end the global TB epidemic through reduced incidence, mortality and catastrophic costs.
  • Focuses on integrated patient-centred care, bold policies and supportive systems, and intensified research and innovation.

India's TB Mukt Bharat Abhiyan

  • National initiative to accelerate TB elimination through active case finding, early diagnosis, treatment and community participation.
  • Encourages community support through the Ni-kshay Mitra initiative, under which individuals and organisations adopt and support TB patients with nutritional and other assistance.

Prelims Question

Q1. With reference to the Global End TB Strategy of the World Health Organization (WHO), consider the following statements:

  1. It was adopted by the World Health Assembly in 2014.
  2. It uses 2015 as the baseline year for measuring reductions in TB incidence and mortality.
  3. It aims to reduce TB deaths by 95% by 2035 compared with the 2015 baseline.
  4. It focuses exclusively on improving medical treatment and does not include social protection or addressing the economic burden of TB.

Which of the statements given above are correct?

(a) 1 and 2 only
(b) 1, 2 and 3 only
(c) 2, 3 and 4 only
(d) 1, 2, 3 and 4

Answer: (b) 

Explanation:

  • Statement 1 is Correct: The WHO adopted the End TB Strategy in 2014.
  • Statement 2 is Correct: The strategy uses 2015 as the baseline year.
  • Statement 3 is Correct: The target is a 95% reduction in TB deaths by 2035.
  • Statement 4 is Incorrect: The strategy also emphasises social protection, patient-centred care, supportive policies and reduction of catastrophic costs.